Chronic Liver Disease Clinical Trials

136 clinical trials for Chronic Liver Disease across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months. — RECRUITING
• Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency — RECRUITING · PHASE4
• Measuring Patient Reported Needs in Outpatient Liver Disease Management — RECRUITING
• Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease — RECRUITING
• Referral of Patients to Hepatology With Hepatoscope — RECRUITING · NA
• Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers — RECRUITING · NA
• Copper Supplementation in Cirrhosis — RECRUITING · NA
• FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. — RECRUITING · NA
• An Observational Study of Patients With Chronic Liver Disease — RECRUITING
• In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop — RECRUITING · PHASE3
• Endoscopic Ultrasound Shear Wave Elastography Study — RECRUITING
• hepatomiR cACLD Study — RECRUITING
• EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG — RECRUITING · NA
• D-SOLVE Cohorts (Cohort a and B) — RECRUITING
• Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant — RECRUITING · NA
• Albumin Modifications as Early Biomarkers of Chronic Liver Diseases — RECRUITING · NA
• Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis — RECRUITING · PHASE4
• Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease — RECRUITING
• An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis — RECRUITING
• Nottingham Community Liver Biomarkers Cohort — RECRUITING
• Pharmacokinetics, pharmacodynamics, safety, and tolerability of an acetonic milk thistle extract, standardized to silymarin, in subjects with MASLD — TERMINATED · PHASE1
• Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia — COMPLETED
• Multicenter, randomized, double-blind, comparative clinical trial to assess the efficacy of Zinc Acexamate versus a placebo in improving the prognosis of patients with advanced chronic liver disease (cACLD). — TERMINATED · PHASE3
• Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients. — NOT_YET_RECRUITING · NA
• Identification of Patients With Advanced Chronic Diseases in Need of Palliative Care — ACTIVE_NOT_RECRUITING
• A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults — NOT_YET_RECRUITING · PHASE1
• Ultrasound Prediction of Esophageal Variceal Bleeding Risk — NOT_YET_RECRUITING
• EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement — COMPLETED · NA
• Increlex Treatment of Children With Chronic Liver Disease and Short Stature — WITHDRAWN · NA
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults — NOT_YET_RECRUITING · PHASE1
• Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous) — COMPLETED
• Heart Problems in Children With Chronic Liver Disease — NOT_YET_RECRUITING
• Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups. — COMPLETED · PHASE2
• Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in MASLD Related Compensated Advanced Chronic Liver Disease. — COMPLETED
• Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns — COMPLETED · NA
• VIATORR Device Registry — ACTIVE_NOT_RECRUITING
• Comparing Portal Vein Assessment by Intraoperative Doppler and Transesophageal Echocardiography — COMPLETED
• Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases — ACTIVE_NOT_RECRUITING · NA
• The SHUNT-V Study for Varices — COMPLETED · NA
• Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy — COMPLETED
• Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease — NOT_YET_RECRUITING · PHASE2
• Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease — COMPLETED · PHASE4
• Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients — COMPLETED · NA
• Somatic Mutation in Chronic Liver Disease — OTHER
• Pirfenidone and Advanced Liver Fibrosis. — COMPLETED · PHASE2
• Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation — COMPLETED · NA
• Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. — COMPLETED · PHASE2
• ASSESSMENT OF SURGICAL RISK IN PATIENTS WITH CHRONIC LIVER DISEASE USING VOCAL PENN SCORE — OTHER
• Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease. — NOT_YET_RECRUITING
• PatientSpot Formerly Known as ArthritisPower — OTHER

Refine this search